brianajackson / iStockphoto.com
The US Court of Appeals for the Federal Circuit has partly affirmed, partly reversed and partly vacated a dispute between Duke University, based in North Carolina, and biotech company BioMarin Pharmaceutical.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Court of Appeals for the Federal Circuit, PTAB, Duke University, BioMarin, patent, USPTO, Pompe disease, patent infringement